IN2015DN03029A - - Google Patents

Info

Publication number
IN2015DN03029A
IN2015DN03029A IN3029DEN2015A IN2015DN03029A IN 2015DN03029 A IN2015DN03029 A IN 2015DN03029A IN 3029DEN2015 A IN3029DEN2015 A IN 3029DEN2015A IN 2015DN03029 A IN2015DN03029 A IN 2015DN03029A
Authority
IN
India
Prior art keywords
phenylephrine
ketorolac
preservative
antioxidant
injection
Prior art date
Application number
Inventor
Gregory A ; Demopulos
Hui-Rong; Shen
Clark E ; Tedford
Original Assignee
Omeros Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50545210&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2015DN03029(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omeros Corp filed Critical Omeros Corp
Publication of IN2015DN03029A publication Critical patent/IN2015DN03029A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/08—Mydriatics or cycloplegics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Abstract

The present invention relates to stable, preservative- and antioxidant -free liquid formulations of phenylephrine and ketorolac for injection.
IN3029DEN2015 2012-10-24 2013-10-23 IN2015DN03029A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261718026P 2012-10-24 2012-10-24
US201261736179P 2012-12-12 2012-12-12
PCT/US2013/066349 WO2014066485A1 (en) 2012-10-24 2013-10-23 Stable preservative-free mydriatic and anti-inflammatory solutions for injection

Publications (1)

Publication Number Publication Date
IN2015DN03029A true IN2015DN03029A (en) 2015-10-02

Family

ID=50545210

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3029DEN2015 IN2015DN03029A (en) 2012-10-24 2013-10-23

Country Status (39)

Country Link
US (5) US9066856B2 (en)
EP (2) EP2911511B1 (en)
JP (7) JP6017053B2 (en)
KR (4) KR101808394B1 (en)
CN (2) CN104822265A (en)
AP (1) AP2015008459A0 (en)
AR (1) AR093115A1 (en)
AU (1) AU2013201465B2 (en)
BR (1) BR112015009228B1 (en)
CA (1) CA2887772C (en)
CL (1) CL2015001078A1 (en)
CR (1) CR20150233A (en)
CU (1) CU20150037A7 (en)
CY (1) CY1124481T1 (en)
DK (1) DK2911511T3 (en)
EA (1) EA033811B1 (en)
ES (1) ES2875432T3 (en)
GE (1) GEP20186891B (en)
HK (1) HK1213434A1 (en)
HR (1) HRP20210980T1 (en)
HU (1) HUE055537T2 (en)
IL (1) IL238439B2 (en)
IN (1) IN2015DN03029A (en)
LT (1) LT2911511T (en)
MA (1) MA38096B1 (en)
MD (1) MD20150050A2 (en)
MX (2) MX2020012591A (en)
MY (1) MY188474A (en)
NZ (1) NZ628398A (en)
PE (1) PE20150958A1 (en)
PH (1) PH12015500850A1 (en)
PL (1) PL2911511T3 (en)
PT (1) PT2911511T (en)
RS (1) RS62188B1 (en)
SG (1) SG11201502602WA (en)
SI (1) SI2911511T1 (en)
UA (1) UA114650C2 (en)
WO (1) WO2014066485A1 (en)
ZA (1) ZA201502684B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040072809A1 (en) 2002-07-30 2004-04-15 Omeros Corporation Ophthalmologic irrigation solutions and method
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
MX2016004257A (en) * 2013-10-03 2016-08-17 Imprimis Pharmaceuticals Inc Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricatiing thereof.
TWI809304B (en) * 2014-12-01 2023-07-21 奥默羅斯公司 Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditions
CN104856990A (en) * 2015-05-07 2015-08-26 武汉武药科技有限公司 Phenylephrine ketorolac solution and preparation method
US11213480B1 (en) * 2015-08-06 2022-01-04 Hikma Pharmaceuticals International Limited Phenylephrine hydrochloride ready-to-use solution
USD831868S1 (en) 2015-09-17 2018-10-23 Lume Cube, Inc. Compact external light
US10704745B2 (en) 2015-10-13 2020-07-07 Lume Cube, Inc. Mobile light source
EP3503873A4 (en) 2016-08-25 2020-04-15 Harrow IP, LLC Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
US20180318319A1 (en) * 2017-05-04 2018-11-08 Ocular Science, Inc. Compositions and Methods for Treating Eyes and Methods of Preparation
JP7078843B2 (en) * 2018-03-26 2022-06-01 サミー株式会社 Pachinko machine
BR112021007725A2 (en) * 2018-10-26 2021-07-27 Ocuphire Pharma, Inc. methods and compositions for treating presbyopia, mydriasis and other ocular disorders
US11071724B2 (en) 2019-05-17 2021-07-27 Ocular Science, Inc. Compositions and methods for treating presbyopia
DE102019125430B3 (en) * 2019-09-20 2020-11-19 Carl Zeiss Meditec Ag Control device for an ophthalmic surgical system, ophthalmic surgical system and computer program product
KR20210087352A (en) 2020-01-02 2021-07-12 삼성전자주식회사 Semiconductor devices having air spacer
US20210228507A1 (en) * 2020-01-22 2021-07-29 Nevakar Inc. Phenylephrine Hydrochloride Compositions and Containers
CN115368310A (en) 2021-05-18 2022-11-22 奥库菲尔医药公司 Method for synthesizing phentolamine mesylate
US20230039551A1 (en) 2021-07-23 2023-02-09 Somerset Therapeutics, Llc Buffer- and chelator-free, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof
CN115950992B (en) * 2023-03-15 2023-06-09 苏州朗易生物医药研究有限公司 Detection method for related substances in phenylephrine ketorolac solution and application thereof

Family Cites Families (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4402949A (en) 1979-11-12 1983-09-06 Sandoz Ltd. Stable solutions of hydrogenated ergotalkaloids
US4550022A (en) 1981-10-05 1985-10-29 Alcon Laboratories, Inc. Tissue irrigating solution
JPS58126810A (en) 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd Ophthalmic anti-inflammatory solution and preparation thereof
US4474751A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
WO1987007141A1 (en) 1986-05-23 1987-12-03 New England Medical Center Hospitals, Inc. Method for treating glaucoma
US5212196A (en) 1986-10-21 1993-05-18 Alcon Laboratories, Inc. Control of post-surgical intraocular pressure using clonidine derivatives
US4938970A (en) 1987-02-06 1990-07-03 Hustead Robert E Painless electrolyte solutions
US5110493A (en) 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
US4876250A (en) 1988-10-31 1989-10-24 Alcon Laboratories, Inc. Methods for controlling ocular hypertension with angiostatic steroids
US5036046A (en) 1988-10-12 1991-07-30 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
US5051443A (en) 1988-10-12 1991-09-24 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
US5371078A (en) 1988-10-31 1994-12-06 Alcon Laboratories, Inc. Angiostatic steroids and methods and compositions for controlling ocular hypertension
US5116868A (en) 1989-05-03 1992-05-26 The Johns Hopkins University Effective ophthalmic irrigation solution
CA2065375A1 (en) 1989-08-21 1991-02-22 Richard J. Sharpe Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists
US5679650A (en) * 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
EP0502143B1 (en) 1990-09-07 1995-11-08 Universidad De Alicante Composition for treating ocular pain
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
IT1252692B (en) 1991-11-27 1995-06-23 Zambon Spa PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC USE CONTAINING A NON-STEROID ANTI-INFLAMMATORY AND A DECONGESTANT AS ACTIVE INGREDIENTS
EP0619739A1 (en) 1992-10-21 1994-10-19 Alcon Laboratories, Inc. Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery
US6117907A (en) 1993-04-14 2000-09-12 Sher; Neal A. Topical treatment of ocular pain after corneal surgery
WO1995009004A1 (en) 1993-09-29 1995-04-06 Alcon Laboratories, Inc. Compositions containing growth factors and antiplastic agents
WO1995009003A1 (en) 1993-09-29 1995-04-06 Alcon Laboratories, Inc. Compositions containing growth factors and antimetabolites
US5624893A (en) 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
AU1399695A (en) 1993-12-17 1995-07-03 Alcon Laboratories, Inc. Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
US6350781B1 (en) 1994-01-14 2002-02-26 Lee Shahinia, Jr. Method and analgesic preparations for sustained and extended corneal analgesia with subanesthetic concentrations of lidocaine
WO1995034298A1 (en) 1994-06-10 1995-12-21 Telor Ophthalmic Pharmaceuticals, Inc. Inhibition of intraoperative miosis/production of mydriasis by local anesthetics
US5523316A (en) 1994-06-23 1996-06-04 Alcon Laboratories, Inc. Intraocular irrigating solution containing agent for controlling IOP
CA2206119C (en) 1994-12-12 2008-05-13 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
KR100517210B1 (en) 1994-12-12 2006-06-07 오메로스 코포레이션 Infusion solution for pain, inflammation and spasm
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
WO2000023061A2 (en) 1998-10-21 2000-04-27 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
AU4467396A (en) 1994-12-12 1996-07-10 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
WO2000023072A1 (en) 1998-10-20 2000-04-27 Omeros Medical Systems, Inc. Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation
US6492332B1 (en) 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
US5972326A (en) 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
US5612027A (en) 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber
US5767105A (en) 1995-05-03 1998-06-16 Peyman; Gholam A. Ocular solution
US5798356A (en) 1995-08-07 1998-08-25 Alcon Laboratories, Inc. Angiostatic compounds
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6413961B1 (en) 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
US6280745B1 (en) 1997-12-23 2001-08-28 Alliance Pharmaceutical Corp. Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
EP1039818A4 (en) 1996-07-26 2001-11-07 Schein Dental Equipment Co Armrest mechanism for dental chairs
GB9704352D0 (en) 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
AU6883798A (en) 1997-04-02 1998-10-22 Regents Of The University Of California, The Method of anesthesia
US5811446A (en) 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
US6034256A (en) 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
US6495598B1 (en) 1997-04-22 2002-12-17 Ophtecs Corporation Perfusate preparation for ophthalmic operation
EP0903151A1 (en) 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
ATE311928T1 (en) 1998-07-01 2005-12-15 Warner Lambert Co (-)-PSEUDOEPHEDRINE AS A SYMPATHOMIMETIC DRUG
CN1114401C (en) 1998-07-14 2003-07-16 阿尔康实验室公司 Use of 11-(3-dimethylaminoprpylidene)-6,11-dihydrodibenz [b,e] oxepin-2-acetic acid for manufacture of medicament for treating non-allergic ophthalmic inflammatory disorders
US6262066B1 (en) 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
FR2782721B1 (en) 1998-09-01 2000-11-03 Inst Nat Sante Rech Med NOVEL PHOSPHOHALOHYDRIN COMPOUNDS, MANUFACTURING METHOD AND APPLICATIONS
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US7973068B2 (en) 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
EP1227807B1 (en) 1998-10-20 2005-03-30 Omeros Corporation Irrigation solution and method for inhibition of pain and inflammation
US20030087962A1 (en) 1998-10-20 2003-05-08 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
EP1434573A2 (en) 1998-10-20 2004-07-07 Omeros Corporation Irrigation solution and method for inhibition of pain and inflammation
AU1345000A (en) 1998-11-05 2000-05-22 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
US6433007B1 (en) 1998-12-17 2002-08-13 Alcon Manufacturing, Ltd. Methods for the prevention and treatment of post-surgical complications
RU2286157C2 (en) * 1999-03-02 2006-10-27 Витрио-Ретинол Текнолоджиз, Инк. Means for introducing into vitreous body for treating or preventing ophthalmic diseases
CN1353573A (en) 1999-05-14 2002-06-12 加利福尼亚大学董事会 Anti-inflammatory therapy for inflammatory mediated infection
WO2001041550A2 (en) 1999-10-22 2001-06-14 Transdermatech, Inc. Topical anesthetic formulation
US6218428B1 (en) 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
AU2001257326A1 (en) 2000-04-28 2001-11-12 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
PE20020146A1 (en) 2000-07-13 2002-03-31 Upjohn Co OPHTHALMIC FORMULATION INCLUDING A CYCLOOXYGENASE-2 (COX-2) INHIBITOR
JP2004503601A (en) 2000-07-13 2004-02-05 ファルマシア・コーポレーション Use of COX-2 inhibitors in the treatment and prevention of ocular COX-2-mediated diseases
JP2004503593A (en) 2000-07-14 2004-02-05 アラーガン、インコーポレイテッド Compositions comprising a therapeutically active ingredient with increased solubility
WO2002009702A2 (en) 2000-07-28 2002-02-07 Inspire Pharmaceuticals, Inc. Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
JP2002161032A (en) 2000-09-14 2002-06-04 Taisho Pharmaceut Co Ltd Composition applied to mucous membrane
CN1390124A (en) 2000-09-20 2003-01-08 永光制药有限公司 Medicine for preventing or treating myopia
US20020183279A1 (en) 2001-04-18 2002-12-05 Koichiro Tanaka Pharmaceutical composition containing viscoelastic substance and medication
US20020198209A1 (en) 2001-05-03 2002-12-26 Allergan Sales Inc. Compositions having enhanced pharmacokinetic characteristics
US20030191187A1 (en) 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
US20040072809A1 (en) 2002-07-30 2004-04-15 Omeros Corporation Ophthalmologic irrigation solutions and method
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
EP1833461A1 (en) * 2004-12-22 2007-09-19 Schering Corporation Pharmaceutical formulations
AU2005322305B2 (en) 2004-12-23 2010-09-16 Roxro Pharma, Inc. Therapeutic compositions for intranasal administration of ketorolac
FR2882930B1 (en) 2005-03-09 2009-03-27 Walid Katib NOVEL OPHTHALMOLOGICAL COMPOSITIONS AND THEIR USE
DOP2007000055A (en) * 2006-04-10 2007-10-31 Senosiain S A De C V Lab PHARMACEUTICAL COMPOSITION INCLUDING AN ANALGESIC AND VITAMINS
EP2185112A4 (en) 2007-08-21 2012-01-18 Harbor Biosciences Inc Stabilized therapeutic compositions and formulations
EP2219630A2 (en) 2007-11-08 2010-08-25 Aciex Therapeutics, Inc. Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor
US9192571B2 (en) 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
US7842714B2 (en) 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
EP2403532A4 (en) * 2009-03-06 2012-12-05 Medimmune Llc Humanized anti-cd19 antibody formulations
US8277781B2 (en) 2009-03-13 2012-10-02 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
CA2764477A1 (en) * 2009-06-05 2010-12-09 Aciex Therapeutics, Inc. Ophthalmic formulations, methods of manufacture, and methods of using same
JP2012528889A (en) * 2009-06-05 2012-11-15 アーシエックス セラピューティックス， インコーポレイテッド Fluticasone ophthalmic formulation and method of use
US8680510B2 (en) 2010-06-28 2014-03-25 International Business Machines Corporation Method of forming compound semiconductor
EP3434257A1 (en) 2010-07-29 2019-01-30 Allergan, Inc. Preservative free brimonidine and timolol solutions
AU2013201465B2 (en) * 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
TWI809304B (en) 2014-12-01 2023-07-21 奥默羅斯公司 Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditions

Also Published As

Publication number Publication date
MA38096B1 (en) 2019-12-31
EP2911511A1 (en) 2015-09-02
MX2015005089A (en) 2015-07-17
ZA201502684B (en) 2016-01-27
KR20170128640A (en) 2017-11-22
KR20200000487A (en) 2020-01-02
WO2014066485A1 (en) 2014-05-01
MA38096A1 (en) 2016-10-31
CY1124481T1 (en) 2022-07-22
HK1213434A1 (en) 2016-07-08
KR102211784B1 (en) 2021-02-04
US9855246B2 (en) 2018-01-02
JP2015535250A (en) 2015-12-10
ES2875432T3 (en) 2021-11-10
MX2020012591A (en) 2022-11-04
PH12015500850B1 (en) 2015-06-22
IL238439B2 (en) 2023-11-01
AP2015008459A0 (en) 2015-05-31
US20140235691A1 (en) 2014-08-21
CU20150037A7 (en) 2015-08-27
US20150342928A1 (en) 2015-12-03
JP2023041804A (en) 2023-03-24
AU2013201465B2 (en) 2016-03-03
US20180085349A1 (en) 2018-03-29
CL2015001078A1 (en) 2015-09-04
KR101808394B1 (en) 2017-12-12
CA2887772C (en) 2017-02-21
JP2016196511A (en) 2016-11-24
GEP20186891B (en) 2018-09-10
BR112015009228B1 (en) 2022-07-19
JP2020147606A (en) 2020-09-17
JP2017014294A (en) 2017-01-19
KR20150068990A (en) 2015-06-22
EP2911511A4 (en) 2015-12-16
SG11201502602WA (en) 2015-05-28
IL238439A0 (en) 2015-06-30
JP6282699B2 (en) 2018-02-21
CA2887772A1 (en) 2014-05-01
DK2911511T3 (en) 2021-06-28
HRP20210980T1 (en) 2021-09-17
NZ628398A (en) 2016-03-31
EP2911511B1 (en) 2021-04-14
LT2911511T (en) 2021-07-26
RS62188B1 (en) 2021-08-31
PL2911511T3 (en) 2021-11-15
BR112015009228A8 (en) 2022-07-12
PH12015500850A1 (en) 2015-06-22
IL238439B1 (en) 2023-07-01
US9066856B2 (en) 2015-06-30
MD20150050A2 (en) 2015-09-30
CR20150233A (en) 2015-08-14
UA114650C2 (en) 2017-07-10
US20170196838A1 (en) 2017-07-13
CN104822265A (en) 2015-08-05
JP6017053B2 (en) 2016-10-26
JP2019081798A (en) 2019-05-30
US20220175726A1 (en) 2022-06-09
PE20150958A1 (en) 2015-07-09
EA201590807A1 (en) 2015-11-30
AU2013201465A1 (en) 2014-05-08
SI2911511T1 (en) 2021-09-30
JP2018058905A (en) 2018-04-12
PT2911511T (en) 2021-07-06
BR112015009228A2 (en) 2017-07-04
CN108721210A (en) 2018-11-02
AR093115A1 (en) 2015-05-20
MY188474A (en) 2021-12-13
HUE055537T2 (en) 2021-12-28
KR102496463B1 (en) 2023-02-06
EP3909572A1 (en) 2021-11-17
US9486406B2 (en) 2016-11-08
KR20210018954A (en) 2021-02-18
EA033811B1 (en) 2019-11-27

Similar Documents

Publication Publication Date Title
IN2015DN03029A (en)
PH12016501151A1 (en) Nrf2 regulators
UY34587A (en) STABILIZED FORMULATIONS CONTAINING ANTIANG2 ANTIBODIES
JO3773B1 (en) P2x7 modulators
IN2015DN00127A (en)
EA201590887A1 (en) COMPOSITION
PH12014501032A1 (en) 2-thiopyrimidinones
JO3154B1 (en) Trpv4 antagonists
MX2014005510A (en) Novel compositions, preparation thereof and use thereof for production of cast polyamides.
MX2014001368A (en) Stable anti-inflammatory solutions for injection.
AU2018253594A1 (en) Dihydroxyphenyl neurotransmitter compounds, compositions and methods
MX2014015039A (en) Fbxo3 inhibitors.
BR112013027222A2 (en) extended release composition containing peptides as active ingredient
UA117567C2 (en) Galactagogue compositions based on phosphatidylserine
MX367773B (en) Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof.
IN2013MU03317A (en)
MY151659A (en) Photopolymerizable Resin Composition
IN2015DN02647A (en)
UA80618U (en) Use of n-steroylethanolamine as radiomodifier
UA105703C2 (en) 7-bromo-5-phenyl-3-arylamino-1,2-dihydro-3h-1,4-benzdiazepin-2-ones as analgetic agents
UA106373C2 (en) Use of pollentarum as an agent with frigoprotective action
UA72478U (en) Use of polentar as frigoprotector
UA96060C2 (en) Use of lipoflavone as agent with frigoprotective action
IN2015DN01285A (en)
IN2012DE01204A (en) "shikhar technology"